Difference between revisions of "FHIR Chemotherapy IG"
Peter Lamb (talk | contribs) |
Peter Lamb (talk | contribs) |
||
Line 41: | Line 41: | ||
== Documents == | == Documents == | ||
+ | * Jun. 2017: Meeting Minutes: [[File:Meeting_Minutes_20_June_2017.pdf]] | ||
* Apr. 2017: Meeting Minutes: [[File:Meeting_Minutes_25_April_2017.pdf]] | * Apr. 2017: Meeting Minutes: [[File:Meeting_Minutes_25_April_2017.pdf]] | ||
* Apr. 2017: Meeting Minutes: [[File:Meeting_Minutes_18_April_2017.pdf]] | * Apr. 2017: Meeting Minutes: [[File:Meeting_Minutes_18_April_2017.pdf]] |
Revision as of 13:25, 21 June 2017
Contents
Welcome to the HL7 FHIR Chemotherapy IG Wiki!
The FHIR Chemotherapy Implementation Guide (IG) helps to ensure that chemotherapy-related medical information is properly represented in HL7 FHIR, and addresses the needs of ordering chemotherapy in various scenarios and countries. This wiki page is for facilitation of ongoing discussions.
Leadership
Mary Visceglia National Comprehensive Cancer Network (NCCN) (Visceglia@nccn.org)
Marten Smits Furore (m.smits@furore.com)
Project Sponsors
Primary sponsor: Clinical Decision Support
Co-sponsors: Pharmacy, Patient Care
Project Information
At the January 2017 Working Group Meeting in San Antonio, TX, participants convened to discuss the creation of a group dedicated to representing chemotherapy-related medical information in FHIR. There was quite a bit of interest among members from many different countries, and we decided to set up an international chemotherapy implementation guide to address this need.
Communication
Please subscribe to the "chemotherapy IG" stream on chat.fhir.org to get involved and start receiving the most up-to-date information about the project!
You can also send comments to the stream via e-mail at zulipfhir+chemotherapy%0032IG+32c8198d004cbb4e504ffc25bbc3cca7@gmail.com. The e-mail body will become the stream message and the e-mail subject will become the stream topic.
Repository
Source for the International Chemotherapy Implementation Guide is located here: https://github.com/cqframework/chemotherapy-ig. It has been connected to the IG build tooling so that commits to the repository automatically result in a build that is published here: http://build.fhir.org/ig/cqframework/chemotherapy-ig/.
Meetings
- Note: Today's meeting (June 6) has been cancelled.
- The next scheduled meeting is June 20, 2017 - 11:30am-12:30pm (Eastern Time Zone).
We have a recurring biweekly meeting on Tuesdays from 11:30am-12:30pm (Eastern Time Zone). The next meetings are schedule for June 20th, July 4, July 18, August 1, etc. Occasionally we will hold additional meetings or reschedule the meeting date/time as needed -- these changes will be posted here.
Please join the teleconference/webex meeting by clicking here: Meeting link. The meeting number is 732819955. The US/Canada call-in toll-free number is 1-866-469-3239, and global call-in numbers are available by clicking here: Global call-in list.
- May 23, 2017 - 11am-12pm (Eastern Time Zone)
- May 2, 2017 - 11:30am-12:30pm (Eastern Time Zone)
- April 25, 2017 - 11am-12pm (Eastern Time Zone)
- April 18, 2017 - 11am-12pm (Eastern Time Zone)
- April 11, 2017 - 11am-12pm (Eastern Time Zone)
- March 28, 2017 - 11am-12pm (Eastern Time Zone)
- March 13, 2017 - 11am-12pm (Eastern Time Zone)
Documents
- Jun. 2017: Meeting Minutes: File:Meeting Minutes 20 June 2017.pdf
- Apr. 2017: Meeting Minutes: File:Meeting Minutes 25 April 2017.pdf
- Apr. 2017: Meeting Minutes: File:Meeting Minutes 18 April 2017.pdf
- Apr. 2017: Meeting Minutes: File:Meeting Minutes 11 April 2017.pdf
- Mar. 2017: Regimen information: File:Dose Dense AC regimen for breast cancer.pdf
- Mar. 2017: Meeting Minutes: File:Meeting Minutes 28 March 2017.pdf
- Mar. 2017: Meeting Minutes: File:Meeting Minutes 13 March 2017.pdf
- Mar. 2017: FHIR Applications Roundtable Presentation: File:NCCN Representing Chemotherapy in FHIR Duke Applications Roundtable March 2017.pdf
- Jan. 2017: Project Scope Statement: File:International Chemotherapy Implementation Guide PSS.docx
Website Facilitator
Peter Lamb National Comprehensive Cancer Network (NCCN) (Lamb@nccn.org)
Please let me know about any content changes, updates, etc. Thanks!
Acknowledgements
Bryn Rhodes Database Consulting Group LLC (bryn@databaseconsultinggroup.com)
Lee Surprenant IBM (lmsurpre@us.ibm.com)